Clinical Trial Update: Assessment of Translesional Markers and Metabolomics

View source ↗

Summary

A completed study assessing translesional markers and metabolomic profiles in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Emory University | Conditions: Coronary Artery Disease | Status: COMPLETED